Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Non-cash Items: 2016-2024

Historic Non-cash Items for Collegium Pharmaceutical (COLL) over the last 9 years, with Dec 2024 value amounting to $7.0 million.

  • Collegium Pharmaceutical's Non-cash Items rose 22.31% to $66.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.2 million, marking a year-over-year increase of 22.31%. This contributed to the annual value of $7.0 million for FY2024, which is 47.02% down from last year.
  • Collegium Pharmaceutical's Non-cash Items amounted to $7.0 million in FY2024, which was down 47.02% from $13.3 million recorded in FY2023.
  • In the past 5 years, Collegium Pharmaceutical's Non-cash Items registered a high of $13.3 million during FY2023, and its lowest value of $2.4 million during FY2020.
  • In the last 3 years, Collegium Pharmaceutical's Non-cash Items had a median value of $8.0 million in 2022 and averaged $9.4 million.
  • In the last 5 years, Collegium Pharmaceutical's Non-cash Items spiked by 155.78% in 2021 and then plummeted by 47.02% in 2024.
  • Collegium Pharmaceutical's Non-cash Items (Yearly) stood at $2.4 million in 2020, then skyrocketed by 155.78% to $6.1 million in 2021, then surged by 31.02% to $8.0 million in 2022, then skyrocketed by 67.19% to $13.3 million in 2023, then crashed by 47.02% to $7.0 million in 2024.